Invesco China Health Care Equity Fd.C H
LU2243645046
Invesco China Health Care Equity Fd.C H/ LU2243645046 /
NAV2024. 05. 30. |
Vált.-0,0100 |
Hozam típusa |
Investment Focus |
Alapkezelő |
4,6700SGD |
-0,21% |
Újrabefektetés |
Részvény
Sector Health / Pharma
|
Invesco Management ▶ |
Befektetési stratégia
The objective of the Fund is to achieve long term capital growth. The Fund invests in Chinese healthcare companies listed on the Shanghai or Shenzhen Stock Exchanges, traded via Stock Connect as well as those listed or traded elsewhere, included Qualified Foreign Investors (QFI). The Fund invests in companies which are attractively valued and demonstrate sustainable growth, along with a strong business model and sound balance sheet. For the purposes of the Fund, healthcare companies include (but are not limited to) companies in the sectors of pharmaceuticals, biotechnology, healthcare services and medical technology and supplies.
The Fund may use derivatives (complex instruments) to manage the Fund more efficiently, with the aim of reducing risk, reducing costs and/or generating additional capital or income. The Fund is actively managed and is not constrained by its benchmark, MSCI China A Onshore Health Care Index, which is used for comparison purposes. However, as the benchmark is a suitable proxy for the investment strategy, it is likely that some of the Fund"s holdings are also components of the benchmark. As an actively managed fund, this overlap will change and this statement may be updated from time to time.
Befektetési cél
The objective of the Fund is to achieve long term capital growth. The Fund invests in Chinese healthcare companies listed on the Shanghai or Shenzhen Stock Exchanges, traded via Stock Connect as well as those listed or traded elsewhere, included Qualified Foreign Investors (QFI). The Fund invests in companies which are attractively valued and demonstrate sustainable growth, along with a strong business model and sound balance sheet. For the purposes of the Fund, healthcare companies include (but are not limited to) companies in the sectors of pharmaceuticals, biotechnology, healthcare services and medical technology and supplies.
Törzsadatok
Hozam típusa: |
Újrabefektetés |
Alapok Kategória: |
Részvény |
Ország: |
Kína |
Ágazat: |
Sector Health / Pharma |
Benchmark: |
MSCI China A Onshore Health Care Index |
Üzleti év kezdete: |
02. 29. |
Last Distribution: |
- |
Letétkezelő bank: |
- |
Származási hely: |
Luxemburg |
Elosztás engedélyezése: |
Ausztria, Németország, Svájc |
Alapkezelő menedzser: |
Chris Liu, Kehong Jiang |
Alap forgalma: |
486,11 mill.
EUR
|
Indítás dátuma: |
2020. 12. 15. |
Befektetési fókusz: |
- |
Feltételek
Kibocsátási felár: |
5,00% |
Max. Administration Fee: |
1,00% |
Minimum befektetés: |
1 200 000,00 SGD |
Deposit fees: |
0,01% |
Visszaváltási díj: |
0,00% |
Egyszerűsített tájékoztató: |
Letöltés (Nyomtatási változat) |
Alapkezelő
Alapkezelő cégek: |
Invesco Management |
Cím: |
An der Welle 5, 60322, Frankfurt am Main |
Ország: |
Németország |
Internet: |
www.de.invesco.com
|
Eszközök
Részvények |
|
96,91% |
Készpénz |
|
3,09% |
Országok
Kína |
|
65,14% |
Készpénz |
|
3,09% |
Kajmán-szigetek |
|
3,05% |
Egyéb |
|
28,72% |
Ágazatok
Gyógyászat/Biotechnológia |
|
50,29% |
Gyógyászati termékek/eszközök |
|
14,53% |
Egészségügyi szolgáltatások |
|
3,36% |
Készpénz |
|
3,09% |
Egyéb |
|
28,73% |